John Driskell Hopkins on ALS research and coping with his diagnosis
Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...
John Driskell Hopkins on new song and $3 million donation for ALS research
After his ALS diagnosis, Zac Brown Band's John Driskell Hopkins plans to donate $3 million to fund research through his "Hop ...
TMCnet10h
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
Amyotrophic Lateral Sclerosis Disease Program (PMN267) PMN267 is a humanized IgG1 antibody directed against toxic misfolded TDP-43 as a potential therapeutic target for amyotrophic lateral sclerosis ...
FierceBiotech2d
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
Clene price target lowered to $83 from $86 at Canaccord
Canaccord analyst Sumant Kulkarni lowered the firm’s price target on Clene (CLNN) to $83 from $86 and keeps a Buy rating on the shares.
Steakhouse owner Al Biernat, one of Dallas' most connected restaurateurs, has died after ALS battle
Dallas steakhouse owner Al Biernat, whose charismatic presence at his namesake restaurant attracted both the famous and the ...
STAT3d
Fueled by a ‘fall off your chair’ discovery and $101 million, Trace launches to take on ALS
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...
Key pathway leading to neurodegeneration in early stages of ALS identified
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
'We’re here to keep up the fight': Idaho Pizza Company ALS fundraiser
Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...
Business Wire2d
Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...